Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tretinoin gel 0.05% in female subjects with classical rosacea
NCT00621218Phase 2Completed
- Sponsor
- Coria Laboratories Ltd.
- Start
- Feb 2008
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rosacea comparing Tretinoin Gel 0.05% with Vehicle (2 arms). Primary endpoint: Improvement in signs and symptoms of rosacea at 16 weeks. Started Feb 2008; status: completed.
02
Drugs
tretinoin
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT00621218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621218.